These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12186152)

  • 21. Reducing coronary artery disease by decreasing homocysteine levels.
    Coffey M; Crowder GK; Cheek DJ
    Crit Care Nurse; 2003 Feb; 23(1):25-30. PubMed ID: 12640957
    [No Abstract]   [Full Text] [Related]  

  • 22. Homocysteine, traditional risk factors and impaired renal function in coronary artery disease.
    Pizzolo F; Friso S; Olivieri O; Martinelli N; Bozzini C; Guarini P; Trabetti E; Faccini G; Corrocher R; Girelli D
    Eur J Clin Invest; 2006 Oct; 36(10):698-704. PubMed ID: 16968465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rationale and design for the CARDIOVIT Study (Cardiovit, Atherosclerotic vascular disease and hypeRhomocysteinemia: an epiDemiological study in Indians, additionally evaluating the effect of Oral VITamin supplementation).
    Shenoy KT; Lena KB; Sali N; Syam S; Shenoy ST; Rajadhyaksha VD; Pai GP; Shaikh AA;
    Curr Med Res Opin; 2006 Apr; 22(4):641-8. PubMed ID: 16684424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Homocysteine as the factor of atherosclerosis risk].
    Jołda-Mydłowska B
    Pol Merkur Lekarski; 2004 May; 16(95):480-3. PubMed ID: 15518433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperhomocysteinemia as a cardiovascular risk factor in Indian women: determinants and directionality.
    Pandey SN; Vaidya AD; Vaidya RA; Talwalkar S
    J Assoc Physicians India; 2006 Oct; 54():769-74. PubMed ID: 17214272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association of homocysteine and coronary artery disease.
    Gauthier GM; Keevil JG; McBride PE
    Clin Cardiol; 2003 Dec; 26(12):563-8. PubMed ID: 14677809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronary risk attributes, coronary risk reduction, and clinical outcomes.
    Wenger NK; Weber MA; Scheidt S
    Am J Geriatr Cardiol; 2006; 15(3):140-1. PubMed ID: 16687965
    [No Abstract]   [Full Text] [Related]  

  • 28. Risk factors for heart disease.
    Tavares EF; Vieira-Filho JP; Andriolo A; Perez AB; Vergani N; Sañudo A; Gimeno SG; Franco LJ
    Ethn Dis; 2004; 14(1):159. PubMed ID: 15002937
    [No Abstract]   [Full Text] [Related]  

  • 29. Hyperhomocysteinemia and the risk of restenosis after coronary artery stenting: fact or fiction?
    Tabrizchi R
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):935-9. PubMed ID: 15500438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Risk factors for cardiovascular diseases: what is the role for homocysteine?].
    Bendini MG; Lanza GA; Mazza A; Giordano A; Leggio M; Menichini G; De Cristofaro R; Moriconi E; Cozzari L; Farina SM; Giordano G
    G Ital Cardiol (Rome); 2007 Mar; 8(3):148-60. PubMed ID: 17461357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Retinal vein occlusion and hyperhomocysteinemia].
    Blondel J; Glacet-Bernard A; Bayani N; Blacher J; Lelong F; Nordmann JP; Coscas G; Soubrane G
    J Fr Ophtalmol; 2003 Mar; 26(3):249-53. PubMed ID: 12746600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperhomocysteinemia and lower extremity wounds.
    Schwartzfarb EM; Romanelli P
    Int J Low Extrem Wounds; 2008 Sep; 7(3):126-36. PubMed ID: 18757388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma homocysteine: an independent or an interactive risk factor for coronary artery disease.
    Gupta M; Sharma P; Garg G; Kaur K; Bedi GK; Vij A
    Clin Chim Acta; 2005 Feb; 352(1-2):121-5. PubMed ID: 15653106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hostility and serum homocysteine as cardiovascular risk factors in Korean patients with coronary artery disease.
    Son YJ
    J Clin Nurs; 2007 Apr; 16(4):672-8. PubMed ID: 17402948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homocysteine, lipid indices and antioxidants in patients with ischaemic heart disease from Maharashtra, India.
    Bhagwat VR; Yadav AS; Rathod IM
    Singapore Med J; 2009 Apr; 50(4):418-24. PubMed ID: 19421689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective cohort study of predictive value of homocysteine in patients with type 2 diabetes and coronary artery disease.
    Ndrepepa G; Kastrati A; Braun S; Koch W; Kölling K; Mehilli J; Schömig A
    Clin Chim Acta; 2006 Nov; 373(1-2):70-6. PubMed ID: 16814762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are we losing homocysteine as a cardiovascular risk factor?
    Bunout D; Hirsch S
    Nutrition; 2005 Oct; 21(10):1068-9. PubMed ID: 16157246
    [No Abstract]   [Full Text] [Related]  

  • 38. Homocysteine levels in acromegaly patients.
    Hekimsoy Z; Ozmen B; Ulusoy S
    Neuro Endocrinol Lett; 2005 Dec; 26(6):811-4. PubMed ID: 16380700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homocysteine increases the risk associated with hyperlipidaemia.
    Daly C; Fitzgerald AP; O'Callaghan P; Collins P; Cooney MT; Graham IM;
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):150-5. PubMed ID: 19276985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic and environmental influences on total plasma homocysteine and coronary artery disease (CAD) risk among South Indians.
    Vinukonda G; Shaik Mohammad N; Md Nurul Jain J; Prasad Chintakindi K; Rama Devi Akella R
    Clin Chim Acta; 2009 Jul; 405(1-2):127-31. PubMed ID: 19394322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.